Maravai LifeSciences Holdings, Inc. Income Taxes Paid
Maravai LifeSciences Holdings, Inc. (MRVI) reported Income Taxes Paid of $23.03 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2023-02-28
- Maravai LifeSciences Holdings, Inc. income taxes paid for the quarter ending 2022-12-31 was $3.45M, a 41.55% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. income taxes paid for the quarter ending 2022-09-30 was $5.72M, a 23.48% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. income taxes paid for the quarter ending 2022-06-30 was $12.94M, a 103.43% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. income taxes paid for the quarter ending 2022-03-31 was $914.00K, a 66.46% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. income taxes paid for fiscal 2022 was $23.03M, a 2.49% increase from fiscal 2021.
- Maravai LifeSciences Holdings, Inc. income taxes paid for fiscal 2021 was $22.47M, a 348.92% increase from fiscal 2020.
- Maravai LifeSciences Holdings, Inc. income taxes paid for fiscal 2020 was $5.01M, a 524.19% increase from fiscal 2019.
- Maravai LifeSciences Holdings, Inc. income taxes paid for fiscal 2019 was $802.00K.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2022-12-31 | $3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $9.18M derived: sum of 2 quarters · filed 2023-02-28 | $22.12M derived: sum of 3 quarters · filed 2023-02-28 | $23.03M 10-K · filed 2023-02-28 |
| 2022-09-30 | $5.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $18.67M derived: sum of 2 quarters · filed 2022-11-04 | $19.58M 10-Q · filed 2022-11-04 | $25.48M derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-06-30 | $12.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $13.86M 10-Q · filed 2022-08-05 | $19.76M derived: sum of 3 quarters · filed 2023-02-28 | $27.24M derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-03-31 | $914.00K 10-Q · filed 2022-05-06 | $6.82M derived: sum of 2 quarters · filed 2023-02-28 | $14.30M derived: sum of 3 quarters · filed 2023-02-28 | $20.66M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $13.39M derived: sum of 2 quarters · filed 2023-02-28 | $19.75M derived: sum of 3 quarters · filed 2023-02-28 | $22.47M 10-K · filed 2023-02-28 |
| 2021-09-30 | $7.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $13.84M derived: sum of 2 quarters · filed 2022-11-04 | $16.57M 10-Q · filed 2022-11-04 | $18.07M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $6.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $9.09M 10-Q · filed 2022-08-05 | $10.59M derived: sum of 3 quarters · filed 2023-02-28 | $14.09M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $2.73M 10-Q · filed 2022-05-06 | $4.22M derived: sum of 2 quarters · filed 2023-02-28 | $7.73M derived: sum of 3 quarters · filed 2023-02-28 | $7.73M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $5.01M derived: sum of 2 quarters · filed 2023-02-28 | $5.01M derived: sum of 3 quarters · filed 2023-02-28 | $5.01M 10-K · filed 2023-02-28 |
| 2020-09-30 | $3.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $3.51M derived: sum of 2 quarters · filed 2021-11-15 | $3.51M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $0.00 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $802.00K 10-K · filed 2022-03-01 |